L'Italo-Americano1d
Glass masters bring nature to life in new exhibit at Tacoma’s Museum of Glass
Even if creepy crawlers are not your thing, there is plenty to see and appreciate at Field Notes: Artists Observe Nature, a ...
Birds & Blooms on MSN3d
The 51 Best Spring Bird Pictures Ever
You won't want to miss these beautiful bird pictures! Each photo was submitted by a Birds & Blooms reader and showcases the ...
Fine-feathered friends: Local bird lovers unite at Spokane Valley shop
Photos of neon-feathered beauties beckon customers through the double doors of My First Bird. Nestled in the corner of a ...
Smithsonian Magazine on MSN1d
See 15 Captivating Images From the British Wildlife Photography Awards, From a Majestic Shark to Hungry Pigeons
The winning photographs highlight the diversity of animal and plant life in Britain as well as the often hidden behaviors of ...
National Audubon Society2d
A Close-Up Look at the Beauty of Backyard Birds
In her watercolor triptych, Rosalie Haizlett celebrates the vibrant colors and details found in the feathers of common—and ...
Democrat and Chronicle5d
From joyous celebrations to birds taking flight, see some of Shawn Dowd's favorite photos
My favorite photo from the past year was of Brighton head coach Stephen Lian gets a cooler of ice water dumped on him by his team as they celebrate their victory over Canandaigua during their ...
Local artist hopes you see how beautiful and beneficial birds are, too
Silent Skies” — an exhibition of paintings and drawings of critically endangered and extinct birds — is on display at the ...
pharmaphorum2d
FDA rejection of Spero's tebipenem 'raises resistance threat'
The FDA's decision not to approve Spero Therapeutics' oral antibiotic tebipenem Hbr for adults with complicated urinary tract infections (cUTI) further increases the threat of antibiotic ...
pharmaphorum2d
Undeterred by FDA setback, GSK snaps up Spero antibiotic
GSK is paying $66 million upfront to license rights to Spero Therapeutics novel antibiotic tebipenem Hbr, unswayed by the FDA's decision earlier this year not to approve the drug for adults with ...